MARK1 antibody (AA 6-40)
Quick Overview for MARK1 antibody (AA 6-40) (ABIN3031687)
Target
See all MARK1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 6-40
-
Purpose
- MARK1 Antibody
-
Purification
- Purified
-
Immunogen
- A portion of amino acids 6-40 from the human protein was used as the immunogen for this MARK1 antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Titration of the MARK1 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the MARK1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- MARK1 (MAP/microtubule Affinity-Regulating Kinase 1 (MARK1))
-
Alternative Name
- MARK1
-
Background
- MARK is a family of kinases that is known for its involvement in establishing cell polarity and in phosphorylating tau protein during Alzheimer neurodegeneration. Expression of MARK causes the phosphorylation of MAPs at their KXGS motifs, thereby detaching MAPs from the microtubules and thus facilitating the transport of particles. This occurs without impairing the intrinsic activity of motors because the velocity during active movement remains unchanged. In primary retinal ganglion cells, transfection with tau leads to the inhibition of axonal transport of mitochondria, APP vesicles, and other cell components which leads to starvation of axons and vulnerability against stress. This transport inhibition can be rescued by phosphorylating tau with MARK
-
UniProt
- Q9P0L2
-
Pathways
- SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Target
-